Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T15:42:28.523Z.
Calculation as of: 2026-10-06T15:42:28.523Z.
Quote observation: 2026-10-06T15:40:26.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e0aae41c25609cbe98cd8c59fbdc20e812e1ea61d6a67e0b8df2c56749153647
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2024-03-26.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
EV/SALES RATIO AVG TTM
N/A
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Kyverna Therapeutics, Inc.
Market Cap
$390.00M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$385.22M
EV/Sales Ratio
0.62x
TTM Avg
0.77x
3Y Avg
0.83x
5Y Avg
0.91x
Market Cap
$397.92M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$380.08M
EV/Sales Ratio
8.89x
TTM Avg
2.21x
3Y Avg
2.18x
5Y Avg
9.49x
Market Cap
$402.83M
EV/Sales Ratio
0.62x
TTM Avg
0.69x
3Y Avg
1.51x
5Y Avg
2.02x
Market Cap
$374.70M
EV/Sales Ratio
1.44x
TTM Avg
1.43x
3Y Avg
2.68x
5Y Avg
18.63x
Market Cap
$409.89M
EV/Sales Ratio
6.67x
TTM Avg
6.44x
3Y Avg
6.66x
5Y Avg
6.66x
Market Cap
$413.94M
EV/Sales Ratio
N/A
TTM Avg
0.91x
3Y Avg
12.05x
5Y Avg
12.05x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | $390.00M | N/A | N/A | N/A | N/A |
| Orthofix Medical Inc. (OFIX)vs › | $385.22M | 0.62x | 0.77x | 0.83x | 0.91x |
| MapLight Therapeutics, Inc. (MPLT)vs › | $397.92M | N/A | N/A | N/A | N/A |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $380.08M | 8.89x | 2.21x | 2.18x | 9.49x |
| Myriad Genetics, Inc. (MYGN)vs › | $402.83M | 0.62x | 0.69x | 1.51x | 2.02x |
| Canopy Growth Corporation (CGC)vs › | $374.70M | 1.44x | 1.43x | 2.68x | 18.63x |
| Carlsmed, Inc. (CARL)vs › | $407.77M | 6.06x | 3.70x | 3.81x | 3.81x |
| Shoulder Innovations, Inc. (SI)vs › | $409.89M | 6.67x | 6.44x | 6.66x | 6.66x |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $413.94M | N/A | 0.91x | 12.05x | 12.05x |
| Neurogene Inc. (NGNE)vs › | $414.19M | N/A | 403.83x | 403.83x | 403.83x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2024-03-26 | 3753.61x |
| 2024-03-25 | 3505.93x |
| 2024-03-22 | 3885.10x |
| 2024-03-21 | 4065.51x |
| 2024-03-20 | 3935.55x |
| 2024-03-19 | 4004.35x |
| 2024-03-18 | 4042.57x |
| 2024-03-15 | 4495.13x |
| 2024-03-14 | 4469.14x |
| 2024-03-13 | 4551.70x |
| 2024-03-12 | 4386.58x |
| 2024-03-11 | 4461.49x |
| 2024-03-08 | 4336.12x |
| 2024-03-07 | 4352.94x |
| 2024-03-06 | 4273.44x |
| 2024-03-05 | 4248.98x |
| 2024-03-04 | 4187.82x |
| 2024-03-01 | 4195.46x |
| 2024-02-29 | 4106.79x |
| 2024-02-28 | 4244.39x |
| 2024-02-27 | 4158.77x |
| 2024-02-26 | 4239.80x |
| 2024-02-23 | 4215.34x |
| 2024-02-22 | 4105.26x |
| 2024-02-21 | 4164.89x |
| 2024-02-20 | 4265.79x |
| 2024-02-16 | 4463.02x |
| 2024-02-15 | 4501.25x |
| 2024-02-14 | 4522.65x |
| 2024-02-13 | 4495.13x |
| 2024-02-12 | 4528.77x |
| 2024-02-09 | 4554.76x |
| 2024-02-08 | 4539.47x |
